A canine BCAN microdeletion associated with episodic falling syndrome

Neurobiology of Disease

Volumn 45, Issue 1, 2012, Pages 130-136

  Gill, Jennifer L ^a   Tsai, Kate L ^b   Krey, Christa ^c   Noorai, Rooksana E ^b   Vanbellinghen, Jean François ^d   Garosi, Laurent S ^e   Shelton, G Diane ^f   Clark, Leigh Anne ^b   Harvey, Robert J ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b CLEMSON UNIVERSITY   (United States)

^c Institut de Pathologie et de Génétique ASBL ^*  (New Zealand)

^d Institut de Pathologie et de Génétique ASBL   (Belgium)

^e DAVIES VETERINARY SPECIALISTS   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BCAN; Brevican; Cavalier King Charles spaniels; Episodic falling syndrome; Microdeletion

Indexed keywords

BREVICAN; GENOMIC DNA;

ANIMAL TISSUE; ARTICLE; BREEDING; BREVICAN GENE; CHROMOSOME 7; CONTROLLED STUDY; DOG; EPISODIC FALLING SYNDROME; GENE; GENE DELETION; GENE LOCUS; GENE MAPPING; GENE MICRODELETION; GENE MUTATION; GENETIC ASSOCIATION; GENOME SIZE; GENOTYPE; HETEROZYGOTE; MOLECULAR GENETICS; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MULTIPLEX POLYMERASE CHAIN REACTION; MUSCLE HYPERTONIA; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

EID: 81955162964     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.07.014     Document Type: Article

References (32)

1. Bekku Y., Rauch U., Ninomiya Y., Oohashi T. Brevican distinctively assembles extracellular components at the large diameter nodes of Ranvier in the CNS. J Neurochem 2009, 108:1266-1276.
2. Bekku Y., Vargová L., Goto Y., Vorísek I., Dmytrenko L., Narasaki M., et al. Bral1: its role in diffusion barrier formation and conduction velocity in the CNS. J Neurosci 2010, 30:3113-3123.
3. Brakebusch C., Seidenbecher C.I., Asztely F., Rauch U., Matthies H., Meyer H., Krug M., Böckers T.M., Zhou X., Kreutz M.R., Montag D., Gundelfinger E.D., Fässler R. Brevican-deficient mice display impaired hippocampal CA1 long-term potentiation but show no obvious deficits in learning and memory. Mol Cell Biol 2002, 22:7417-7427.
4. Chuzhanova N., Abeysinghe S., Krawczak M., Cooper D. Translocation and gross deletion breakpoints in human inherited disease and cancer II: potential involvement of repetitive sequence elements in secondary structure formation between DNA ends. Hum Mut 2003, 22:245-251.
5. De Fusco M., Becchetti A., Patrignani A., Annesi G., Gambardella A., Quattrone A., et al. The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 2000, 26:275-276.
6. Drögemüller C., Becker D., Brunner A., Haase B., Kircher P., Seeliger F., Fehr M., Baumann U., Lindblad-Toh K., Leeb T. A missense mutation in the SERPINH1 gene in Dachshunds with osteogenesis imperfecta. PLoS Genet 2009, 5:e1000579.
7. Engel A.G., Banker B.Q. Ultrastructural changes in diseased muscle. Myology 2004, 749-887. McGraw-Hill, New York. 3rd ed. A.G. Engel, C.F. Franzini-Armstrong (Eds.).
8. Garosi L.S., Platt S.R., Shelton G.D. Hypertonicity in Cavalier King Charles spaniels. J Vet Intern Med 2002, 16:330.
9. Gill J.L., Capper D., Vanbellinghen J.F., Chung S.K., Higgins R.J., Rees M.I., et al. Startle disease in Irish wolfhounds associated with a microdeletion in the glycine transporter GlyT2 gene. Neurobiol Dis 2011, 43:184-189.
10. Gleghorn L., Ramesar R., Beighton P., Wallis G. A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis. Am J Hum Genet 2005, 77:484-490.
11. Harvey R.J., Topf M., Harvey K., Rees M.I. The genetics of hyperekplexia: more than startle!. Trends Genet 2008, 24:439-447.
12. Herrtage M.E., Palmer A.C. Episodic falling in the cavalier King Charles spaniel. Vet Rec 1983, 112:458-459.
13. Hirakawa S., Oohashi T., Su W.D., Yoshioka H., Murakami T., Arata J., Ninomiya Y. The brain link protein-1 (BRAL1): cDNA cloning, genomic structure, and characterization as a novel link protein expressed in adult brain. Biochem Biophys Res Commun 2000, 276:982-989.
14. Karlsson E.K., Baranowska I., Wade C.M., Salmon Hillbertz N.H., Zody M.C., Anderson N., et al. Efficient mapping of mendelian traits in dogs through genome-wide association. Nat Genet 2007, 39:1321-1328.
15. Laing N.G., Wilton S.D., Akkari P.A., Dorosz S., Boundy K., Kneebone C., et al. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet. 1995, 9:75-79.
16. Maeda N., Fukazawa N., Ishii M. Chondroitin sulfate proteoglycans in neural development and plasticity. Front Biosci 2010, 15:626-644.
17. Matthews E., Hanna M.G. Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis?. J Physiol 2010, 588:1879-1886.
18. Miyamoto T., Inoue H., Sakamoto Y., Kudo E., Naito T., Mikawa T., et al. Identification of a novel splice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome. Invest Ophthalmol Vis Sci 2005, 46:2726-2735.
19. Oohashi T., Hirakawa S., Bekku Y., Rauch U., Zimmermann D.R., Su W.D., et al. Bral1, a brain-specific link protein, colocalizing with the versican V2 isoform at the nodes of Ranvier in developing and adult mouse central nervous systems. Mol Cell Neurosci 2002, 19:43-57.
20. Patterson E.E., Minor K.M., Tchernatynskaia A.V., Taylor S.M., Shelton G.D., Ekenstedt K.J., Mickelson J.R. A canine DNM1 mutation is highly associated with the syndrome of exercise-induced collapse. Nat Genet 2008, 40:1235-1239.
21. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575.
22. Rees M.I., Lewis T.M., Kwok J.B., Mortier G.R., Govaert P., Snell R.G., et al. Hyperekplexia associated with compound heterozygote mutations in the β-subunit of the human inhibitory glycine receptor (GLRB). Hum Mol Genet 2002, 11:853-860.
23. Rees M.I., Harvey K., Pearce B.R., Chung S.K., Duguid I.C., Thomas P., et al. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nat Genet 2006, 38:801-806.
24. Rusbridge C. Neurological diseases of the Cavalier King Charles spaniel. J Small Anim Pract 2005, 46:265-272.
25. Schouten J.P., McElgunn C.J., Waaijer R., Zwijnenburg D., Diepvens F., Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002, 30:e57.
26. Shiang R., Ryan S.G., Zhu Y.Z., Hahn A.F., O'Connell P., Wasmuth J.J. Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet 1993, 5:351-358.
27. Stattin E.L., Wiklund F., Lindblom K., Onnerfjord P., Jonsson B.A., Tegner Y., et al. A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans. Am J Hum Genet 2010, 86:126-137.
28. Thomas R.H., Stephenson J.B.P., Harvey R.J., Rees M.I. Hyperekplexia: stiffness, startle and syncope. J Ped Neurol 2010, 8:11-14.
29. Tomlinson S.E., Hanna M.G., Kullmann D.M., Tan S.V., Burke D. Clinical neurophysiology of the episodic ataxias: insights into ion channel dysfunction in vivo. Clin Neurophysiol. 2009, 120:1768-1776.
30. Weber Y.G., Lerche H. Genetics of paroxysmal dyskinesias. Curr Neurol Neurosci Rep 2009, 9:206-211.
31. Wright J.A., Brownlie S.E., Smyth J.B., Jones D.G., Wotton P. Muscle hypertonicity in the cavalier King Charles spaniel-myopathic features. Vet Rec 1986, 118:511-512.
32. Wright J.A., Smyth J.B., Brownlie S.E., Robins M. A myopathy associated with muscle hypertonicity in the Cavalier King Charles spaniel. J Comp Pathol 1987, 97:559-565.